Back to Search
Test Name REF LAB SOLID TUMOR EXPANDED PANEL
Orderable CPT -
OVT 123002561
Synonyms -
Result Test Name QUEST CLINICAL TRIALS 10
Laboratory QUEST LAB
Result Test Code 12386029996
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 1
Laboratory QUEST LAB
Result Test Code 12386030013
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 1
Laboratory QUEST LAB
Result Test Code 12386030015
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 10
Laboratory QUEST LAB
Result Test Code 12386029994
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 8
Laboratory QUEST LAB
Result Test Code 12386029976
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 9
Laboratory QUEST LAB
Result Test Code 12386029987
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 10
Laboratory QUEST LAB
Result Test Code 12386029993
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 4
Laboratory QUEST LAB
Result Test Code 12386029949
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 53844-7
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 4
Laboratory QUEST LAB
Result Test Code 12386029950
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 31208-2
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 2
Laboratory QUEST LAB
Result Test Code 12386029940
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 21739-8
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 3
Laboratory QUEST LAB
Result Test Code 12386029943
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 4
Laboratory QUEST LAB
Result Test Code 12386029948
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 2
Laboratory QUEST LAB
Result Test Code 12386029939
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 100027-2
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 11
Laboratory QUEST LAB
Result Test Code 12386030074
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 12
Laboratory QUEST LAB
Result Test Code 12386030079
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 12
Laboratory QUEST LAB
Result Test Code 12386030084
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 10
Laboratory QUEST LAB
Result Test Code 12386030068
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 6
Laboratory QUEST LAB
Result Test Code 12386030046
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 7
Laboratory QUEST LAB
Result Test Code 12386030053
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 8
Laboratory QUEST LAB
Result Test Code 12386030055
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 12
Laboratory QUEST LAB
Result Test Code 12386030083
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALWAYS STATEMENT
Laboratory QUEST LAB
Result Test Code 12386030090
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST REVIEWER
Laboratory QUEST LAB
Result Test Code 12386030088
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE REGIONS PASSING QC
Laboratory QUEST LAB
Result Test Code 12386030085
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST PUBLICATION
Laboratory QUEST LAB
Result Test Code 12386030089
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 2
Laboratory QUEST LAB
Result Test Code 12386030020
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 2
Laboratory QUEST LAB
Result Test Code 12386030022
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 4
Laboratory QUEST LAB
Result Test Code 12386030033
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 6
Laboratory QUEST LAB
Result Test Code 12386030044
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 10
Laboratory QUEST LAB
Result Test Code 12386029992
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 12
Laboratory QUEST LAB
Result Test Code 12386030005
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ADDITIONAL VARIANTS
Laboratory QUEST LAB
Result Test Code 12386030012
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 100028-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 1
Laboratory QUEST LAB
Result Test Code 12386030016
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 9
Laboratory QUEST LAB
Result Test Code 12386029985
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 10
Laboratory QUEST LAB
Result Test Code 12386029990
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 7
Laboratory QUEST LAB
Result Test Code 12386029974
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 9
Laboratory QUEST LAB
Result Test Code 12386029984
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 1
Laboratory QUEST LAB
Result Test Code 12386029930
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 20990-8
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 7
Laboratory QUEST LAB
Result Test Code 12386030051
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 11
Laboratory QUEST LAB
Result Test Code 12386030075
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 4
Laboratory QUEST LAB
Result Test Code 12386030035
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 6
Laboratory QUEST LAB
Result Test Code 12386030048
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 4
Laboratory QUEST LAB
Result Test Code 12386030032
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 12
Laboratory QUEST LAB
Result Test Code 12386030008
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 3
Laboratory QUEST LAB
Result Test Code 12386030025
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 3
Laboratory QUEST LAB
Result Test Code 12386030027
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 12
Laboratory QUEST LAB
Result Test Code 12386030080
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 12
Laboratory QUEST LAB
Result Test Code 12386030081
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 10
Laboratory QUEST LAB
Result Test Code 12386030070
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 11
Laboratory QUEST LAB
Result Test Code 12386030073
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 9
Laboratory QUEST LAB
Result Test Code 12386030066
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 8
Laboratory QUEST LAB
Result Test Code 12386030058
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 9
Laboratory QUEST LAB
Result Test Code 12386030065
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 6
Laboratory QUEST LAB
Result Test Code 12386030045
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 10
Laboratory QUEST LAB
Result Test Code 12386030067
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82939-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENES NEGATIVE FOR VARIANTS
Laboratory QUEST LAB
Result Test Code 12386030087
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 8
Laboratory QUEST LAB
Result Test Code 12386029982
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 3
Laboratory QUEST LAB
Result Test Code 12386030029
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 5
Laboratory QUEST LAB
Result Test Code 12386030037
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 6
Laboratory QUEST LAB
Result Test Code 12386030043
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 9
Laboratory QUEST LAB
Result Test Code 12386030062
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 6
Laboratory QUEST LAB
Result Test Code 12386029964
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 7
Laboratory QUEST LAB
Result Test Code 12386029972
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 50398-7
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 8
Laboratory QUEST LAB
Result Test Code 12386029977
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 8
Laboratory QUEST LAB
Result Test Code 12386029981
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST OVERALL INTERPRETATION
Laboratory QUEST LAB
Result Test Code 12386018781
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 47969-1
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 1
Laboratory QUEST LAB
Result Test Code 12386029932
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 21659-8
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 4
Laboratory QUEST LAB
Result Test Code 12386029951
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 4
Laboratory QUEST LAB
Result Test Code 12386029952
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 58415-1
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST BLOCK ID
Laboratory QUEST LAB
Result Test Code 12386007476
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 21702-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 7
Laboratory QUEST LAB
Result Test Code 12386030054
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 8
Laboratory QUEST LAB
Result Test Code 12386030059
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 10
Laboratory QUEST LAB
Result Test Code 12386030071
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 10
Laboratory QUEST LAB
Result Test Code 12386030072
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 11
Laboratory QUEST LAB
Result Test Code 12386030076
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 1
Laboratory QUEST LAB
Result Test Code 12386030014
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 2
Laboratory QUEST LAB
Result Test Code 12386030024
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 3
Laboratory QUEST LAB
Result Test Code 12386030026
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 7
Laboratory QUEST LAB
Result Test Code 12386030049
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 12
Laboratory QUEST LAB
Result Test Code 12386030007
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 12
Laboratory QUEST LAB
Result Test Code 12386030009
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST INTERACTING VARIANTS
Laboratory QUEST LAB
Result Test Code 12386030011
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 42783-1
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 10
Laboratory QUEST LAB
Result Test Code 12386029991
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 11
Laboratory QUEST LAB
Result Test Code 12386029997
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 11
Laboratory QUEST LAB
Result Test Code 12386029999
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 3
Laboratory QUEST LAB
Result Test Code 12386029945
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 93777-1
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 3
Laboratory QUEST LAB
Result Test Code 12386029947
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 31208-2
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 5
Laboratory QUEST LAB
Result Test Code 12386029960
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 21702-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 6
Laboratory QUEST LAB
Result Test Code 12386029968
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 31208-2
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 8
Laboratory QUEST LAB
Result Test Code 12386029978
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 11
Laboratory QUEST LAB
Result Test Code 12386029998
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 12
Laboratory QUEST LAB
Result Test Code 12386030006
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 6
Laboratory QUEST LAB
Result Test Code 12386029967
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 5
Laboratory QUEST LAB
Result Test Code 12386029959
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 21665-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 6
Laboratory QUEST LAB
Result Test Code 12386029966
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 31208-2
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 4
Laboratory QUEST LAB
Result Test Code 12386029954
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 31208-2
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 5
Laboratory QUEST LAB
Result Test Code 12386029955
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 55752-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 5
Laboratory QUEST LAB
Result Test Code 12386030039
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 4
Laboratory QUEST LAB
Result Test Code 12386030034
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 11
Laboratory QUEST LAB
Result Test Code 12386030003
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 2
Laboratory QUEST LAB
Result Test Code 12386030023
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 11
Laboratory QUEST LAB
Result Test Code 12386030001
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 9
Laboratory QUEST LAB
Result Test Code 12386029986
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 9
Laboratory QUEST LAB
Result Test Code 12386029989
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 11
Laboratory QUEST LAB
Result Test Code 12386030000
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 2
Laboratory QUEST LAB
Result Test Code 12386029935
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 100026-4
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 1
Laboratory QUEST LAB
Result Test Code 12386029927
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 30896-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 1
Laboratory QUEST LAB
Result Test Code 12386029928
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 51968-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 1
Laboratory QUEST LAB
Result Test Code 12386029933
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 21665-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST SPECIMEN TYPE
Laboratory QUEST LAB
Result Test Code 12386029925
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 58483-9
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 2
Laboratory QUEST LAB
Result Test Code 12386029937
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 60033-8
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 3
Laboratory QUEST LAB
Result Test Code 12386029946
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 93778-9
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 3
Laboratory QUEST LAB
Result Test Code 12386029942
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 22035-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 9
Laboratory QUEST LAB
Result Test Code 12386029983
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 5
Laboratory QUEST LAB
Result Test Code 12386029958
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 7
Laboratory QUEST LAB
Result Test Code 12386029973
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 6
Laboratory QUEST LAB
Result Test Code 12386029962
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 31208-2
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 2
Laboratory QUEST LAB
Result Test Code 12386029934
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 21702-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 2
Laboratory QUEST LAB
Result Test Code 12386029938
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 47969-1
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 4
Laboratory QUEST LAB
Result Test Code 12386029953
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 78205-2
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 5
Laboratory QUEST LAB
Result Test Code 12386029956
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 12
Laboratory QUEST LAB
Result Test Code 12386030082
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 10
Laboratory QUEST LAB
Result Test Code 12386030069
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 11
Laboratory QUEST LAB
Result Test Code 12386030077
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 11
Laboratory QUEST LAB
Result Test Code 12386030078
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST DIAGNOSIS:
Laboratory QUEST LAB
Result Test Code 12385997341
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 21719-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 6
Laboratory QUEST LAB
Result Test Code 12386030047
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE REGIONS FAILING QC
Laboratory QUEST LAB
Result Test Code 12386030086
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 2
Laboratory QUEST LAB
Result Test Code 12386030021
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 3
Laboratory QUEST LAB
Result Test Code 12386030030
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 1
Laboratory QUEST LAB
Result Test Code 12386030018
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 2
Laboratory QUEST LAB
Result Test Code 12386030019
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST SOURCE
Laboratory QUEST LAB
Result Test Code 12386014128
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 60033-8
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 1
Laboratory QUEST LAB
Result Test Code 12386029929
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 43368-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 9
Laboratory QUEST LAB
Result Test Code 12386030064
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 11
Laboratory QUEST LAB
Result Test Code 12386030002
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 5
Laboratory QUEST LAB
Result Test Code 12386030042
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 7
Laboratory QUEST LAB
Result Test Code 12386030050
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 9
Laboratory QUEST LAB
Result Test Code 12386030061
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 93368-9
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 12
Laboratory QUEST LAB
Result Test Code 12386030004
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 9
Laboratory QUEST LAB
Result Test Code 12386029988
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 10
Laboratory QUEST LAB
Result Test Code 12386029995
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 8
Laboratory QUEST LAB
Result Test Code 12386029979
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 7
Laboratory QUEST LAB
Result Test Code 12386029971
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 31208-2
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 8
Laboratory QUEST LAB
Result Test Code 12386029980
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 93368-9
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 12
Laboratory QUEST LAB
Result Test Code 12386030010
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 3
Laboratory QUEST LAB
Result Test Code 12386030028
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 7
Laboratory QUEST LAB
Result Test Code 12386029975
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 7
Laboratory QUEST LAB
Result Test Code 12386029970
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 29308-4
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 7
Laboratory QUEST LAB
Result Test Code 12386029969
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 5
Laboratory QUEST LAB
Result Test Code 12386029961
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 78205-2
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT 6
Laboratory QUEST LAB
Result Test Code 12386029963
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 55752-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 6
Laboratory QUEST LAB
Result Test Code 12386029965
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 55752-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 1
Laboratory QUEST LAB
Result Test Code 12386029931
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 58483-9
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE NAME 3
Laboratory QUEST LAB
Result Test Code 12386029941
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 30896-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT FREQUENCY 3
Laboratory QUEST LAB
Result Test Code 12386029944
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 5
Laboratory QUEST LAB
Result Test Code 12386029957
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 31208-2
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST ALTERATION TYPE 2
Laboratory QUEST LAB
Result Test Code 12386029936
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 21719-0
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 8
Laboratory QUEST LAB
Result Test Code 12386030056
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 8
Laboratory QUEST LAB
Result Test Code 12386030057
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 8
Laboratory QUEST LAB
Result Test Code 12386030060
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 82786-5
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GUIDELINE FOR APPROVED DRUGS 9
Laboratory QUEST LAB
Result Test Code 12386030063
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 7
Laboratory QUEST LAB
Result Test Code 12386030052
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 5
Laboratory QUEST LAB
Result Test Code 12386030041
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 69548-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST VARIANT EFFECT ON GENE 5
Laboratory QUEST LAB
Result Test Code 12386030038
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST APPROVED DRUGS OTHERS CAN USE 5
Laboratory QUEST LAB
Result Test Code 12386030040
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 48018-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST CLINICAL TRIALS 1
Laboratory QUEST LAB
Result Test Code 12386030017
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST GENE FUNCTION 4
Laboratory QUEST LAB
Result Test Code 12386030031
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC -
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements
Result Test Name QUEST COMPANION DIAGNOSTICS 4
Laboratory QUEST LAB
Result Test Code 12386030036
Laboratory Test Name QUEST SOLID TUMOR EXPANDED PANEL
Reportable Test Name -
Result LOINC 81258-6
Collection Container PATH CONTAINER
Units -
Collection Requirements Preferred Specimen(s) 200 mm2 >=20% tumor content of tumor tissue collected in a formalin-fixed paraffin-embedded tissue Alternative Specimen(s) 10 X 10 um (minimum 5 x 10 um) unstained sections of formalin-fixed paraffin-embedded tissue and 1 x 4 um (minimum 1 x 5 um) section with H & E staining >=20% tumor content (minimum >=10% tumor content) Formalin-fixed paraffin-embedded FNA 50 uL of 20 ng/uL (minimum 10 uL of 10 ng/uL) extracted DNA Minimum Volume 10 mm2 >=10% tumor content Collection Instructions For FFPE and slides a pathology report must be submitted with sample. Do not reject.
Container Temp Room Temperature (1)
Container Volume -
Test Info Solid Tumor Expanded Panel - Solid Tumor Genomics from Quest Advanced Diagnostics - Precision medicine is an emerging approach for disease prevention and treatment that takes individual variability into account. This next-generation sequencing (NGS) panel along with the computational resources and tools that process and analyze the data allows the characterization of individual patients and tumor types. Guidelines exist for using results from many of these genes for selection of FDA approved therapies. This NGS panel can accurately and sensitively sequence more target genes with less DNA with reduced cost time and labor as compared with more limited sequencing methods and the physician can become aware of alternative treatments available to the patient based on presence of mutations in other genes the physicians might not have considered. Microsatellite instability (MSI) and tumor mutation burden (TMB) are also included. The panel allows the generation of diverse data obtained and *
Shipping Instructions Transport Container Formalin-fixed paraffin-embedded tissue block Transport Temperature Room temperature Specimen Stability Tumor tissue Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Unstained sections of FFPE tissue and H & E stained section Room temperature: 28 days Refrigerated: 5 years Frozen: Unacceptable FFPE FNA Room temperature: 5 years Refrigerated: 5 years Frozen: Unacceptable Extracted DNA Room temperature: 14 days Refrigerated: 90 days Frozen: 5 years Reject Criteria Sample with <10% tumor content Sample less than minimal requirements